— Know what they know.
Not Investment Advice
Also trades as: MOOD.CN (CNQ) · $vol 0M

DOSEF OTC

Doseology Sciences Inc.
1W: +0.0% 1M: +0.0% 3M: -0.6% YTD: -68.2% 1Y: -88.9% 3Y: -50.5%
$0.11
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 46 · $501357 mcap · 2M float · 0.014% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$1M -0.6% ▼
5Y CAGR: -1.1%
Total Liabilities
$94K +14.1% ▲
5Y CAGR: +1.3%
Shareholders Equity
$1M +37.1% ▲
5Y CAGR: +5.5%
Cash & Investments
$1M +34.8% ▲
5Y CAGR: +33.2%
Total Debt
$0 +0.0% ▲
Net Debt
-$1M +1.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$4M$2M$1M$1M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$2M$1M$1M$1M
Net Receivables$810K$44K$17K$2K$41K
Inventory$129K$10K$9K$0$17K
Other Current Assets$0$1M$641K$0$0
Total Current Assets$5M$3M$1M$1M$1M
Property, Plant & Equip.$907K$883K$56K$0$0
Goodwill & Intangibles$81K$14K$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$989K$897K$56K$0$0
Total Assets$6M$4M$1M$1M$1M
— Liabilities —
Accounts Payable$47K$61K$91K$47K$32K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$356K$0$0$0$0
Other Current Liabilities$3M-$226K$0$0-$13K
Total Current Liabilities$3M$219K$92K$82K$69K
Long-Term Debt$659K$0$0$0$0
Other Non-Current Liab.-$659K-$6K-$645K$0$0
Total Non-Current Liabilities$659K$653K$8K$0$0
Total Liabilities$3M$872K$99K$82K$94K
— Equity —
Common Stock$5M$7M$7M$7M$8M
Retained Earnings-$2M-$4M-$6M-$6M-$7M
Accumulated OCI$108K$284K$367K$0$0
Total Stockholders Equity$3M$3M$1M$1M$1M
Total Liabilities & Equity$6M$4M$1M$1M$1M
— Key Metrics —
Total Debt$688K$746K$50K$0$0
Net Debt-$3M-$1M-$1M-$1M-$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms